- Home
- VRCA vs MKTW Comparison
VRCA vs MKTW Comparison
Compare VRCA & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- MKTW
- Stock Information
- Founded
- VRCA 2013
- MKTW 1999
- Country
- VRCA United States
- MKTW United States
- Employees
- VRCA N/A
- MKTW N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- VRCA Health Care
- MKTW Technology
- Exchange
- VRCA Nasdaq
- MKTW Nasdaq
- Market Cap
- VRCA 58.7M
- MKTW 48.2M
- IPO Year
- VRCA 2018
- MKTW N/A
- Fundamental
- Price
- VRCA $4.82
- MKTW $17.37
- Analyst Decision
- VRCA Hold
- MKTW Hold
- Analyst Count
- VRCA 5
- MKTW 1
- Target Price
- VRCA $60.00
- MKTW $20.00
- AVG Volume (30 Days)
- VRCA 36.2K
- MKTW 11.8K
- Earning Date
- VRCA 11-03-2025
- MKTW 11-06-2025
- Dividend Yield
- VRCA N/A
- MKTW 4.50%
- EPS Growth
- VRCA N/A
- MKTW 59.71
- EPS
- VRCA N/A
- MKTW 2.83
- Revenue
- VRCA $14,704,000.00
- MKTW $358,121,000.00
- Revenue This Year
- VRCA $264.34
- MKTW N/A
- Revenue Next Year
- VRCA $33.95
- MKTW N/A
- P/E Ratio
- VRCA N/A
- MKTW $6.27
- Revenue Growth
- VRCA 5.72
- MKTW N/A
- 52 Week Low
- VRCA $3.82
- MKTW $9.08
- 52 Week High
- VRCA $20.60
- MKTW $21.74
- Technical
- Relative Strength Index (RSI)
- VRCA 34.96
- MKTW 51.19
- Support Level
- VRCA $4.87
- MKTW N/A
- Resistance Level
- VRCA $5.23
- MKTW $18.30
- Average True Range (ATR)
- VRCA 0.33
- MKTW 0.40
- MACD
- VRCA -0.02
- MKTW -0.63
- Stochastic Oscillator
- VRCA 11.03
- MKTW 97.46
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.